Targeted neuronal reprogramming rescues memory and neural synchrony in Alzheimer’s disease
Authors:
Open Access
- 10 June 2026
- journal article
- Published by Springer Nature in Molecular Biomedicine
- Vol. 7 (1)
Abstract
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and represents a major societal burden. Aging is the strongest risk factor for AD, and partial cellular reprogramming using Yamanaka factors (YFs) has recently emerged as a strategy to counteract age-associated dysfunction. However, the mechanisms by which partial reprogramming ameliorates AD-related phenotypes remain poorly defined. Here, we investigated whether targeted and intermittent expression of YFs in hippocampal neurons restores cognitive function and neural network integrity in the P301S mouse model of tauopathy. We first show that controlled YFs expression in hippocampal neurons increases excitatory synaptic transmission and enhances neural synchrony in GCaMP6-expressing neuronal networks. We then induced intermittent, neuron-specific YFs expression for six months in adult control and P301S mice. This intervention led to a sex-dependent improvement in cognitive and emotional behaviors in P301S mice, accompanied by a reduction in Tau pathology and partial restoration of epigenetic aging markers. At the molecular level, reprogramming restored the composition and signaling of N-methyl-D-aspartate receptor (NMDAR) macro-complexes, including key subunits and AD-associated risk factors such as proline-rich tyrosine kinase 2 (PYK2/PTK2B). Importantly, impaired hippocampal neural synchrony observed in P301S mice was also rescued. Together, these findings demonstrate that targeted, partial in vivo neuronal reprogramming reverses behavioral and network-level deficits in a mouse model of AD and identify NMDAR-associated signaling as a potential mechanistic mediator of this effect.Keywords
Funding Information
- Fundación Ramón Areces (CIVP21A7024)
- Ministerio de Ciencia e Innovación (CNS2022 – 135391)
- Ministerio de Ciencia e Innovación (PID2024-157024OB-I00)
This publication has 77 references indexed in Scilit:
- Cellular rejuvenation protects neurons from inflammation-mediated cell deathCell Reports, 2025
- Cognitive rejuvenation in old rats by hippocampal OSKM gene therapyGeroScience, 2024
- Astrocytes constitute the major TNF-α-producing cell population in the infarct cortex in dMCAO rats receiving intravenous MSC infusionBiomedicine & Pharmacotherapy, 2021
- The history of long‐term potentiation as a memory mechanism: Controversies, confirmation, and some lessons to rememberHippocampus, 2020
- Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington’s DiseaseMolecular Neurobiology, 2019
- Progressive age-dependent motor impairment in human tau P301S overexpressing miceBehavioural Brain Research, 2019
- Cerebral transcriptome analysis reveals age-dependent progression of neuroinflammation in P301S mutant tau transgenic male miceBrain, Behavior, and Immunity, 2019
- Klf4 Interacts Directly with Oct4 and Sox2 to Promote ReprogrammingStem Cells, 2009
- Glycogen Synthase Kinase 3β Is Tyrosine Phosphorylated by PYK2Biochemical and Biophysical Research Communications, 2001
- Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205Neuroscience Letters, 1995